Status:

COMPLETED

The Impact of Amniotic Fluid Index (AFI) on Maternal and Perinatal Outcomes in Pregnant Women With Preterm Premature Rupture of Membranes

Lead Sponsor:

Istanbul Medeniyet University

Conditions:

Premature Rupture of Membrane

Amniotic Fluid Leakage

Eligibility:

FEMALE

18-40 years

Brief Summary

Pregnant women who admitted with the complaint of amniotic fluid leakage between the gestational ages of 23+0 and 33+0 and who finally were diagnosed as PPROM were included in the study. Women with mu...

Detailed Description

Pregnant women who admitted with the complaint of amniotic fluid leakage between the gestational ages of 23+0 and 33+0 were examined for the inclusion criteria of the study. Among them, women with usu...

Eligibility Criteria

Inclusion

  • Pregnant women Diagnosis of PPROM between 23+0 and 33+0 gestational ages. -

Exclusion

  • Multiple gestations, C Cervical dilatation above 6 cm at the admission, Hypertensive diseases, Cervical cerclage, Fetal anomalies, Oligohydramnios, Polihydramnios, Those who declined to participate in the study.
  • \-

Key Trial Info

Start Date :

September 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2019

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT04100252

Start Date

September 1 2018

End Date

September 1 2019

Last Update

September 24 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Istanbul Medeniyet University, Goztepe Research and Training Hospital

Istanbul, Kadikoy, Turkey (Türkiye), 34722

The Impact of Amniotic Fluid Index (AFI) on Maternal and Perinatal Outcomes in Pregnant Women With Preterm Premature Rupture of Membranes | DecenTrialz